The treatment of anxiety disorders in children and adolescents

Biological Psychiatry

Volumn 46, Issue 11, 1999, Pages 1567-1578

  Labellarte, Michael J ^a   Ginsburg, Golda S ^a   Walkup, John T ^a   Riddle, Mark A ^a  

^a Div of Child and Adol Psychiatry   (United States)

Author keywords

Anxiety disorders; Children and adolescents; Cognitive behavioral therapy (CBT); Psychopharmacotherapy

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BUSPIRONE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CLOMIPRAMINE; CLONAZEPAM; DIPHENHYDRAMINE; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; IMIPRAMINE; LORAZEPAM; MEPROBAMATE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PERPHENAZINE; PHENELZINE; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANQUILIZER; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADOLESCENT; ANXIETY NEUROSIS; BEHAVIOR THERAPY; CHILD; CLINICAL TRIAL; COGNITIVE THERAPY; COMPULSION; CONFERENCE PAPER; DISEASE COURSE; HUMAN; MENTAL DISEASE; OBSESSION; PREVALENCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE;

ADOLESCENT; ADOLESCENT PSYCHIATRY; ANXIETY DISORDERS; CHILD; CHILD PSYCHIATRY; CHILD, PRESCHOOL; HUMANS;

EID: 0032752260     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00248-6     Document Type: Conference Paper

References (72)

1. Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry. 36:(suppl):1997;69s-84s.
2. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. 1994;American Psychiatric Press, Washington, DC.
3. Barrett P.M., Dadds M.R., Rapee R.M. Family treatment of childhood anxiety A controlled trial . J Consult Clin Psychol. 64:1996;333-342.
4. Beidel D.C., Turner S.M., Morris T.L. A new instrument to assess childhood anxiety and phobia The Social Phobia and Anxiety Inventory for Children . Psychol Assess. 1:1995;73-79.
5. Beidel D.C., Turner S.M., Taylor-Ferreira J.C. Teaching study-skills and test-taking strategies to elementary school children The Testbusters program . Behav Modif. 23:1999;630-646.
6. Berg C.J., Rapoport J.L., Flament M. The Leyton Obsessional Inventory - Child version. J Am Acad Child Psychiatry. 25:1986;84-91.
7. Berney T., Kolvin I., Bhate S.R., Garside R.F., Jeans J., Kay B., et al. School phobia A therapeutic trial with clomipramine and short-term outcome . Br J Psychiatry. 138:1981;110-118.
8. Bernstein G.A., Garfinkel B.D., Borchardt C.M. Comparative studies of pharmacotherapy for school refusal. J Am Acad Child Adolesc Psychiatry. 29:1990;773-781.
9. Bhangoo R.K., Riddle M.A. Pharmacologic treatment of anxiety disorders in adolescents. Eisman A. Adolescent Psychiatry. 1999;243-270 The Analytic Press, Hillsdale, NY.
10. Birmaher B., Waterman G.S., Ryan N., Cully M., Balach L., Ingram J., Brodsky M. Fluoxetine for childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry. 33:1994;993-999.
11. Birmaher B., Yelovich A.K., Renaud J. Pharmacological treatment for children and adolescents with anxiety disorders. Ped Clin North Am. 45:1998;1187-1204.
12. Black B., Uhde T.W. Treatment of elective mutism with fluoxetine A double-blind, placebo-controlled study . J Am Acad Child Adolesc Psychiatry. 33:1994;1000-1006.
13. Cobham V.E., Dadds M.R., Spence S.H. The role of parental anxiety in the treatment of childhood anxiety. J Consult Clin Psychol. 66:1998;893-905.
14. Costello E.J., Angold A. Epidemiology. March J.S. Anxiety Disorders in Children and Adolescents. 1995;109-124 The Guilford Press, New York.
15. Cytryn L., Gilbert A., Eisenberg L. The effectiveness of tranquilizing drugs plus supportive psychotherapy in treating behavior disorders of children A double blind study of eighty outpatients . Am J Orthopsychiatry. 30:1960;113-128.
16. Dadds M.R., Holland D.E., Laurens K.R., Mullins M., Barrett P.M., Spence S.H. Early intervention and prevention of anxiety disorders in children Results at 2-year follow-up . J Consult Clin Psychol. 67:1999;145-150.
17. Dadds M.R., Spence S.H., Holland D.E., Barrett P.M., Laurens K.R. Prevention and early intervention for anxiety disorders A controlled trial . J Consult Clin Psychol. 65:1997;627-635.
18. D'Amato G. Chlordiazepoxide in management of school phobia. Dis Nerv Syst. 23:1962;292-295.
19. DeHann E., Hoogduin K.A.L., Buitelaar J.K., Keijsers G.P.J. Behavior therapy versus clomipramine for the treatment of OCD in children and adolescents. J Am Acad Child Adolesc Psychiatry. 37:1998;1022-1029.
20. DeVeaugh-Geiss J., Moroz B., Biederman J. Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder - a multicenter trial. J Am Acad Child Adolesc Psychiatry. 31:1992;45-49.
21. Effron A.S., Freedman A.M. The treatment of behavior disorders in children with benadryl. J Pediatr. 42:1953;261-266.
22. Eisenberg L., Gilbert A., Cytryn L., Molling P.A. The effectiveness of psychotherapy alone and in conjunction with perphenazine or placebo in the treatment of neurotic and hyperkinetic children. Am J Psychiatry. 117:1961;1088-1093.
23. Fairbanks J.M., Pine D.S., Tancer N.K., Dummit E.S., Kentgen L.M., Martin J., et al. Open fluoxetine treatment of mixed anxiety disorders in children and adolescents. J Child Adolesc Psychopharmacol. 7:1997;17-29.
24. Fish B. Drug therapy in child psychiatry Pharmacological aspects . Comp Psychiatry. 1:1960;212-227.
25. Fish B., Shapiro T. A typology of children's psychiatric disorders I. Its application to a controlled evaluation of treatment . J Am Acad Child Adolesc Psychiatry. 4:1965;32-52.
26. Flament M.F., Rapoport J.L., Berg C.J., Sceery W., Kilts C., Mellstrom B., et al. Clomipramine treatment of childhood obsessive-compulsive disorder A double-blind controlled study . Arch Gen Psychiatry. 42:1985;977-983.
27. Francis G., Beidel D. Cognitive-behavioral psychotherapy. March J.S. Anxiety Disorders in Children and Adolescents. 1995;321-340 Guilford Press, New York.
28. Franklin M.E., Kozak M.J., Cashman L.A., Coles M.E., Rheingold A.A., Foa E.B. Cognitive-behavioral treatment of pediatric obsessive-compulsive disorder An open clinical trial . J Am Acad Child Adolesc Psychiatry. 37:1998;412-419.
29. Freedman A.M., Effron A.S., Bender L. Pharmacotherapy in children with psychiatric illness. J Nerv Ment Dis. 122:1955;479-486.
30. Freud S. Analysis of a phobia in a 5-year-old boy (1909). Rieff P. The Sexual Enlightenment of Children. 1963;47-143 Macmillan Publishing, New York.
31. Frommer E.A. Treatment of childhood depression with antidepressant drugs. Br Med J. 1:1967;729-732.
32. Gittleman-Klein R., Klein D. Controlled imipramine treatment of school phobia. Arch Gen Psychiatry. 25:1971;204-207.
33. Gittleman-Klein R., Klein D. Relationship between separation anxiety and panic and agoraphobic disorders. Psychopathology. 17:(suppl 1):1984;56-65.
34. Graae F., Milner J., Rizzotto L., Klein R.G. Clonazepam in childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry. 33:1994;372-376.
35. Jones M.C. A laboratory study of fear The case of Peter . J Gen Psychol. 31:1924;308-315.
36. Kashani J.H., Orvashel H. A community study of anxiety in children and adolescents. Am J Psychiatry. 147:1990;313-318.
37. Kendall P.C. Treating anxiety disorders in children Results of a randomized clinical trial . J Consult Clin Psychol. 62:1994;100-110.
38. Kendall P.C., Southam-Gerow M. Long-term follow-up of a cognitive-behavioral therapy for anxiety-disordered youth. J Consult Clin Psychol. 64:1996;724-730.
39. Kendall P.C., Flannery-Schroeder E., Panichelli-Mindell S.M., Southam-Gerow M., Henin A., Warman A. Therapy for youths with anxiety disorders A second randomized clinical trial . J Consult Clin Psychol. 65:1997;366-380.
40. King N.J., Tong B.J., Heyne D., Pritchard M., Rollings S., Young D., et al. Cognitive-behavioral treatment of school-refusing children A controlled evaluation . J Am Acad Child Adolesc Psychiatry. 37:1998;395-403.
41. Klein D.F. Delineation of two drug responsive anxiety syndromes. Psychopharmacologia. 5:1964;397-408.
42. Klein R.G., Kopelwicz H.S., Kanner A. Imipramine treatment in children with separation anxiety disorder. J Am Acad Child Adolesc Psychiatry. 31:1992;21-28.
43. Korein J., Fish B., Shapiro T., Gerner E.W., Levidow T. EEG and behavioral effects of drug therapy in children. Chlorpromazine and diphenhydramine. Arch Gen Psychiatry. 24:1971;552-563.
44. Kraft I.A., Ardali C., Duffy J.H., Hart J.T., Pearce P. A clinical study of chlordiazepoxide used in psychiatric disorders of children. Int J Neuropsychiatry. 1:1965;433-437.
45. Kutcher A.P., Mackenzie S. Successful clonazepam treatment of adolescents with panic disorder. J Clin Psychopharmacol. 8:1988;299-301.
46. Last C.G., Hansen C., Franco N. Cognitive-behavioral treatment of social phobia. J Am Acad Child Adolesc Psychiatry. 37:1998;4,404-4,411.
47. Last C.G., Perrin S., Hersen M., Kazdin A.E. DSM-III-R anxiety disorders in children Sociodemographic and clinical characteristics . J Am Acad Child Adolesc Psychiatry. 31:1992;1070-1076.
48. Last C.G., Strauss C.C. School refusal in anxiety disordered children and adolescents. J Am Acad Child Adolesc Psychiatry. 29:1990;31-35.
49. Leonard H.L., Swedo S.E., Rapoport J.L., Koby E.V., Lenane M.C., Cheslow D.L., et al. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents A double-blind crossover comparison . Arch Gen Psychiatry. 46:1989;1088-1092.
50. March J.S., Biederman J., Wolkow R., Safferman A., Mardekian J., Cook E.H., et al. Sertraline in children and adolescents with obsessive-compulsive disorder A multicenter randomized controlled trial . JAMA. 280:1998;1752-1756.
51. March J.S., Mulle K. Obsessive-compulsive disorder in children and adolescents A cognitive-behavioral treatment manual . 1998;Guilford, New York.
52. March J.S., Mulle K., Herbel B. Behavioral therapy for children and adolescents with obsessive-compulsive disorder An open trial with a protocol driven package . J Am Acad Child Adolesc Psychiatry. 33:1994;333-341.
53. McDougle C.J., Goodman W.K., Leckman J.F., Lee N.C., Heninger G.R., Price L.H. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study with patients with and without tics. Arch Gen Psychiatry. 51:1994;302-308.
54. Pauls D.L., Alsobrook J.P., Goodman W., Rassmussen S., Leckman J.F. A family study of obsessive-compulsive disorder. Am J Psychiatry. 152:1995;72-75.
55. Pfeffer C.R., Jiang H., Domeshek L.J. Buspirone treatment of psychiatrically hospitalized prepubetal children with symptoms of anxiety and moderately severe aggression. J Child Adolesc Psychopharmacol. 7:1997;145-155.
56. Pine D.S., Cohen P., Gurley D., Brook J., Ma Y. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Arch Gen Psychiatry. 55:1998;56-64.
57. Rapoport J., Conners C.K., Reatig N. Clinical Global Impression (CGI) Scale. Psychopharmacol Bull. 21:1985;839-843.
58. Reynolds C.R., Richmond B.O. A revised measure of children's manifest anxiety. J Abnorm Child Psychol. 6:1978;271-280.
59. Riddle M.A., Scahill L., King R.A., Hardin M.T., Anderson G.M., Ort S.I., et al. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 31:1992;1062-1069.
60. Riddle M.A., Subramaniam G., Walkup J.T. Efficacy of psychiatric medications in children and adolescents A review of controlled studies . Psychiatric Clin North Am (Annu Drug Ther). 5:1998;269-285.
61. Rosenberg D.R., Keshavan M.S., O'Hearn K.M., Dick E.L., Bagwell W.W., Seymour A.B., et al. Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Arch Gen Psychiatry. 54:1997;824-830.
62. Scahill L., Riddle M.A., McSwiggen-Hardin M., Ort S.I., King R.A., Goodman W.K., et al. Children's Yale-Brown obsessive compulsive scale reliability and validity . J Am Acad Child Adolesc Psychiatry. 36:1997;844-852.
63. Shaffer D., Gould M.S., Brasic J., Abrosini P., Fisher P., Aluwahlia S. A children's global assessment scale (K-GAS). Arch Gen Psychiatry. 40:1983;1228-1231.
64. Silverman W. Anxiety Disorders Interview Schedule for Children. 1991;Graywind, Albany, NY.
65. Silverman W.K., Kurtines W.M., Ginsburg G.S., Weems C.F., Rabian B., Serafinil L.T. Treating anxiety disorders in children with group cognitive-behavioral therapy A randomized clinical trial . J Consult Clin Psychol. 67:1999;675-687.
66. Simeon J.G., Ferguson H.B. Alprazolam effects in children with anxiety disorders. Can J Psychiatry. 32:1987;570-574.
67. Simeon J.G., Ferguson H.B., Knott V., Roberts N., Gautheir B., Dubois C., et al. Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. J Am Acad Child Adolesc Psychiatry. 31:1992;29-33.
68. Simeon J.G., Knott V.J., Dubois C., Wiggins D., Geraets I., Thatte S., et al. Buspirone therapy of mixed anxiety disorders in childhood and adolescence A pilot study . J Child Adolesc Psychopharmacol. 4:1994;159-170.
69. Walkup J (September 1999): The Pediatric Anxiety Rating Scale (PARS): A reliability study. Poster presented at the 46th annual meeting of the American Academy of Child and Adolescent Psychiatry, Chicago.
70. Watson J.B., Rayner R. Conditioned emotional reactions. J Exper Psychol. 3:1920;1.
71. Westenberg M.P., Siebelink B.M., Warmenhoven N.J.C., Treffers P.D.A. Separation anxiety and overanxious disorders Relations to age and level of psychosocial maturity . J Am Acad Child Adolesc Psychiatry. 38:1999;1000-1007.
72. Wilens T.E., Biederman J., Baldessarini R.J., Geller B., Schleifer D., Spencer T.J., et al. Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. J Am Acad Child Adolesc Psychiatry. 35:1996;1491-1501.